These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 7760096)
1. Amplification and differential expression of members of the erbB-gene family in human glioblastoma. Schlegel J; Stumm G; Brändle K; Merdes A; Mechtersheimer G; Hynes NE; Kiessling M J Neurooncol; 1994; 22(3):201-7. PubMed ID: 7760096 [TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas. Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843 [TBL] [Abstract][Full Text] [Related]
3. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Schlegel J; Merdes A; Stumm G; Albert FK; Forsting M; Hynes N; Kiessling M Int J Cancer; 1994 Jan; 56(1):72-7. PubMed ID: 8262681 [TBL] [Abstract][Full Text] [Related]
4. Expression of neu/c-erbB-2 in human brain tumors. Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508 [TBL] [Abstract][Full Text] [Related]
5. Differential amplification of the TGF-alpha gene in human gliomas. Yung WK; Zhang X; Steck PA; Hung MC Cancer Commun; 1990; 2(6):201-5. PubMed ID: 2165797 [TBL] [Abstract][Full Text] [Related]
6. Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells. Duhem-Tonnelle V; Bièche I; Vacher S; Loyens A; Maurage CA; Collier F; Baroncini M; Blond S; Prevot V; Sharif A J Neuropathol Exp Neurol; 2010 Jun; 69(6):606-22. PubMed ID: 20467331 [TBL] [Abstract][Full Text] [Related]
7. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme. Agosti RM; Leuthold M; Gullick WJ; Yasargil MG; Wiestler OD Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):321-5. PubMed ID: 1314448 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. Aldape KD; Ballman K; Furth A; Buckner JC; Giannini C; Burger PC; Scheithauer BW; Jenkins RB; James CD J Neuropathol Exp Neurol; 2004 Jul; 63(7):700-7. PubMed ID: 15290895 [TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization. Haapasalo H; Hyytinen E; Sallinen P; Helin H; Kallioniemi OP; Isola J Br J Cancer; 1996 Mar; 73(5):620-3. PubMed ID: 8605096 [TBL] [Abstract][Full Text] [Related]
10. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study. Dietzmann K; von Bossanyi P Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278 [TBL] [Abstract][Full Text] [Related]
12. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415 [TBL] [Abstract][Full Text] [Related]
13. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas. Gulati S; Ytterhus B; Granli US; Gulati M; Lydersen S; Torp SH Diagn Pathol; 2010 Mar; 5():18. PubMed ID: 20331873 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Layfield LJ; Willmore C; Tripp S; Jones C; Jensen RL Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):91-6. PubMed ID: 16540738 [TBL] [Abstract][Full Text] [Related]
19. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Newcomb EW; Cohen H; Lee SR; Bhalla SK; Bloom J; Hayes RL; Miller DC Brain Pathol; 1998 Oct; 8(4):655-67. PubMed ID: 9804374 [TBL] [Abstract][Full Text] [Related]
20. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features. Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]